openPR Logo
Press release

Adalimumab Market Report 2021 Global Industry Statistics & Regional Outlook to 2028 -AbbVie Inc., Amgen (Europe) GmbH (A Subsidiary of Amgen Inc.), CELLTRION INC., Samsung Bioepis (a subsidiary of Samsung Biologics), Biogen

07-07-2021 09:47 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

The credible Adalimumab Market report studies and analyses facts and figures about the market segmentation very carefully and represent it in the form of graphs for the better understanding of end user. It not only identifies the emerging trends along with major drivers, challenges and opportunities in the market but also analyses them efficiently. The market report has been specially designed by keeping in mind the customer requirements with which businesses can get assistance in increasing their return on investment (ROI). An international Adalimumab Market report has a lot of features to offer about industry such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis.

adalimumab market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the forecast period of 2020 to 2027 and is expected to reach USD 28,508.07 million by 2027. Rise in the prevalence of rheumatoid arthritis and increasing number of contract research organizations are the major drivers which propelled the demand of the market in the forecast period.

Get Free Sample PDF @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-adalimumab-market

LIST OF TABLES

TABLE 1 GLOBAL ADALIMUMAB MARKET, PIPELINE ANALYSIS

TABLE 2 BIOSIMILAR OF ADALIMUMAB LAUNCHED IN THE U.S.

TABLE 3 PREVALENCE AND INCIDENCE RATES OF RA WORLDWIDE (CASE PER 100 INHABITANTS)

TABLE 4 BIOLOGIC DRUGS SUBJECTED TO PATENT LOSS

TABLE 5 ALTERNATIVE DRUGS FOR INFLAMMATORY DISEASES TREATMENT

TABLE 6 GLOBAL ADALIMUMAB MARKET, BY INDICATION 2019-2027 (USD MILLION)

TABLE 7 GLOBAL RHEUMATOID ARTHRITIS IN ADALIMUMAB MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 8 GLOBAL ANKYLOSING SPONDYLITIS IN ADALIMUMAB MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 9 GLOBAL CHRONIC PLAQUE PSORIASIS IN ADALIMUMAB MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 10 GLOBAL CROHN’S DISEASE IN ADALIMUMAB MARKET, BY REGION, 2017-2027 (USD MILLION)

This Free report sample includes:

A brief introduction to the research report.
Graphical introduction of the regional analysis.
Top players in the market with their revenue analysis.
Selected illustrations of market insights and trends.
Example pages from the report.
For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-adalimumab-market

LIST OF FIGURES

FIGURE 1 GLOBAL ADALIMUMAB MARKET: SEGMENTATION

FIGURE 2 GLOBAL ADALIMUMAB MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL ADALIMUMAB MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL ADALIMUMAB MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL ADALIMUMAB MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL ADALIMUMAB MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL ADALIMUMAB MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL ADALIMUMAB MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL ADALIMUMAB MARKET: VENDOR SHARE ANALYSIS

Leading Key Players:

The major companies which are dealing in the adalimumab are AbbVie Inc., Amgen (Europe) GmbH (A Subsidiary of Amgen Inc.), CELLTRION INC., Samsung Bioepis (a subsidiary of Samsung Biologics), Biogen, Coherus BioSciences, Innovent Biologics, Inc., Mylan N.V., Zydus Cadila, Hetero Biopharma Ltd., Fresenius Kabi Deutschland GmbH (A Subsidiary of Fresenius Kabi AG), Sandoz International GmbH (A Subsidiairy of Sandoz (A Division of Novartis AG)), Pfizer Inc., Boehringer Ingelheim International GmbH, Reliance Life Sciences (A Subsidiary of Reliance Industries Limited) among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-adalimumab-market

Why Choose DBMR?

Regional demand estimation and forecast
Pre-commodity pricing volatility
Technological updates analysis
Location Quotients Analysis
Raw Material Sourcing Strategy
Competitive Analysis
Product Mix Matrix
Vendor Management
Access Full Report Directly @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-adalimumab-market

Advantages of Buying the Report:

Our report is additionally known for its information exactness and granular market investigation

A total image of the serious situation of the at-home testing units market is portrayed by this report.

The broad range of investigation in regards to the significant headways

It likewise gives a total evaluation of things to come market and the changing business sector situation.

Study the market techniques that are being received by your rivals and driving associations.

Key Points Covered in Table of Content:

The report is essentially fragmented into a few key locales, import, fare, income, and piece of the pie and development pace of Microalgae in these areas, from 2021 to 2028, covering:

Presentation: It incorporates the goals and extent of the examination and gives features of key market fragments and players covered.

Leader Summary: It covers industry patterns with high spend significant time in market use cases and top market patterns, piece of the pie by locales, and Microalgae Market size and development by areas.

Central members: Here, the report centers around consolidations and acquisitions, developments, examination of vital participants, establishment date of organizations, and territories served, detailing base, and income of vital participants.

Breakdown by Market Segmentation: This segment gives insights regarding market size by item and application.

Worldwide Microalgae Market, By Geography Analysis: All of the areas and nations examined inside the report are concentrated on market size by item and application, central members, and market figure.

Profiles of International Players: Here, players are assessed on the possibility of their edge of benefit, value, deals, income, business, items, and other organization subtleties.

Market Dynamics: It incorporates store network examination, investigation of territorial promoting, difficulties, openings, and drivers dissected inside the report.

The study of disease transmission of the Research Study

Informative supplement: It incorporates insights concerning examination and philosophy approach, research strategy, information sources, creators of the investigation, and a disclaimer.

Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

About Us:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies ly and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adalimumab Market Report 2021 Global Industry Statistics & Regional Outlook to 2028 -AbbVie Inc., Amgen (Europe) GmbH (A Subsidiary of Amgen Inc.), CELLTRION INC., Samsung Bioepis (a subsidiary of Samsung Biologics), Biogen here

News-ID: 2322884 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for ADALIMUMAB

Adalimumab Biosimilar Market Report and Forecast 2024-2032
Global Adalimumab Biosimilar Market Outlook The adalimumab biosimilar market is expected to grow at a CAGR of about 17.60% in the forecast period of 2024-2032, driven by the rising incidence of rheumatoid arthritis, especially amongst the rapidly growing geriatric population. Adalimumab Biosimilar: Introduction Adalimumab biosimilars are biologic medical products highly similar to the reference product, Humira, which is used to treat autoimmune diseases. These biosimilars offer comparable efficacy, safety, and quality at a
Adalimumab Biosimilar Market Size, Share, Trends 2024-2032
The adalimumab biosimilar market is witnessing substantial growth, driven by the rising incidence of rheumatoid arthritis and an increasing geriatric population. Adalimumab, a popular biologic for treating various inflammatory diseases, has seen a surge in biosimilar counterparts due to their cost-effectiveness and expanding applications. The market is expected to grow at a CAGR of about 17.60% from 2024-2032, reflecting significant opportunities for industry players. Get a Free Sample Report with Table
Adalimumab Market Insights, Forecast to 2031
"Adalimumab Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Adalimumab market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Adalimumab industry, providing stakeholders with a nuanced perspective on market dynamics. Furthermore, the
Adalimumab Market Size, Status & Forecast 2024
Global Adalimumab Market: Overview Adalimumab, with a trade name of Humira and Exemptia, is an anti-TNF drug used for treating rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, psoriasis and ulcerative colitis. Adalimumab usually binds with tumor necrosis factor-alpha (TNFα). When a TNFα binds to a TBFα receptors, it results in an inflammatory response to autoimmune disease. Adalimumab, by binding to a TNFα, lowers the chances of inflammatory response. View Report @ http://www.transparencymarketresearch.com/adalimumab-market.html Adalimumab, which
Adalimumab Market - Forecasts from 2014 to 2020
Adalimumab is a biologic TNF inhibiting anti-inflammatory medication which is a patented medicine of Abbott Biotechnology Ltd. Jochen G. Salfeld et al invented the product and trade names for the product are Exemptia and Humira. Humira stands for "human monoclonal antibody in rheumatoid arthritis". Humira targets and acts as building block for TNF-alpha production, and lowering inflammation. TNF blockers with HUMIRA, has adverse affects on the immune system which
Increasing Research and Penetration of Adalimumab Biosimilars Boosts Demand for …
The impending patent expiration has resulted in the sluggish growth rate of the adalimumab market in Latin America. The entry of biosimilars has further aggravated the market’s concerns. Transparency Market Research (TMR) pegs the valuation of the Latin America adalimumab market at US$994.8 mn in 2014. Expanding at a weak CAGR of 0.4% from 2015 to 2023, the market is forecast to reach US$1,186.4 mn by the end of 2023. Download